Qualitative Research on Global Lung Cancer Therapeutics Industry 2021 oct-21-2016 | Page 4

Global Lung Cancer Therapeutics Market 5.1.1 Chemotherapy 5.1.1.1 Cisplatin 5.1.1.2 Taxol 5.1.1.3 Navelbine 5.1.1.4 Camptosar 5.1.1.5 Alimta 5.1.2 Radiotherapy 5.1.2.1 External Beam 5.1.2.2 Internal Beam 5.1.2.3 Systemic 5.1.3 Other Drugs 5.1.3.1 Abraxane 5.1.3.2 Avastin 5.1.3.3 Crizotinib 5.1.3.4 Docetaxel 5.1.3.5 Gefitinib Request Customization at “http://www.marketdataforecast.com/market-reports/global-lungcancer-therapeutics-market-893/customize-report” 6. Geographical Analysis 6.1 North America 6.1.1 Introduction 6.1.2 United States 6.1.3 Canada 6.2 Europe 6.2.1 Introduction 6.2.2 U.K 6.2.3 Spain 6.2.4 Germany 6.2.5 Italy 6.2.6 France 6.3 Asia-Pacific 6.3.1 Introduction [phone] | www.marketdataforecast.com | [email protected]